Literature DB >> 27956185

Assessing the 'added value' of European policy on new psychoactive substances.

Caroline Chatwin1.   

Abstract

BACKGROUND: New psychoactive substances (NPS) are reported to be on the rise throughout Europe, and are often presented as the latest challenge facing drug-policy makers. At the European level, legislation on NPS has existed since 1998. Several evaluations, however, have suggested that this legislation is not effective and the European Commission has submitted a new proposal on NPS seeking to extend its powers in this area.
METHODS: This article critically evaluates the new proposal against its predecessor's three main criticisms: (i) being unable to tackle the large number of NPS because of lengthy European legislative approaches, (ii) being reactive rather than proactive, and (iii) lacking options for regulatory and control measures. RESULTS AND
CONCLUSION: In determining whether or not European interventions can bring added value to what is being done at the national level, it finds that, while the new proposal is more efficient, it is not necessarily more effective, and that there is a disappointing focus on legal frameworks at the expense of research and harm reduction.
Copyright © 2016 Elsevier B.V. All rights reserved.

Keywords:  Drug policy; European harmonisation; Evidence based policy; Harm reduction; New psychoactive substances

Mesh:

Substances:

Year:  2016        PMID: 27956185     DOI: 10.1016/j.drugpo.2016.11.002

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  3 in total

1.  Mapping novel psychoactive substances policy in the EU: The case of Portugal, the Netherlands, Czech Republic, Poland, the United Kingdom and Sweden.

Authors:  Jessica Neicun; Marthe Steenhuizen; Robin van Kessel; Justin C Yang; Attilio Negri; Katarzyna Czabanowska; Ornella Corazza; Andres Roman-Urrestarazu
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

Review 2.  New Psychoactive Substances: Evolution in the Exchange of Information and Innovative Legal Responses in the European Union.

Authors:  Maria Rosaria Varì; Giulio Mannocchi; Roberta Tittarelli; Laura Leondina Campanozzi; Giulio Nittari; Alessandro Feola; Federica Umani Ronchi; Giovanna Ricci
Journal:  Int J Environ Res Public Health       Date:  2020-11-23       Impact factor: 3.390

3.  New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.

Authors:  Eliza Kurcevič; Rick Lines
Journal:  Harm Reduct J       Date:  2020-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.